Anthera Pharma (ANTH) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Join SI Premium – FREE
Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Morgan Stanley Downgrades Nichirei Corp (2871:JP) to Equalweight
- Semtech surges on strong Q2 beat and upbeat Q3 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
